Identifying biomarkers for idiopathic intracranial hypertension
Official title: Diagnostic and Prognostic Biomarkers of Idiopathic Intracranial Hypertension
Run by Danish Headache Center · NCT04032379 · Data updated 2026-11-12
This study is trying to find specific markers in the body that can help diagnose and predict outcomes for women of childbearing age who might have idiopathic intracranial hypertension.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 300 (estimated) |
| Sponsor | Danish Headache Center Academic / other |
| Locations | 2 sites (Copenhagen, Glostrup and 1 other locations) |
| Status | Recruiting |
| Started | February 14, 2018 |
| Main results expected | May 31, 2027 |
| Study ends | May 31, 2027 |
| Registry record updated | March 7, 2023 |
| Trial ID | NCT04032379 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults over 18 years old who are suspected of having idiopathic intracranial hypertension.
✕Probably not a fit
Patients who are unable to provide informed consent or have conditions that preclude participation will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to identify diagnostic and prognostic biomarkers for idiopathic intracranial hypertension (IIH), a condition primarily affecting overweight females of childbearing age. It involves a multicenter, prospective cohort design where patients suspected of having IIH will be included based on specific criteria. Participants will undergo a series of evaluations, including medical history, neurological and ophthalmological examinations, neuro-imaging, and collection of blood and cerebrospinal fluid samples. The study will create a clinical database to track patient characteristics and outcomes over time.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnostic and prognostic capabilities for patients with idiopathic intracranial hypertension.
How similar studies have gone: While there is ongoing research in this area, the specific approach of identifying biomarkers for IIH is relatively novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Able to and willing to provide informed consent 2. More than 18 years of age 3. Suspicion of IIH (based on clinical evaluation by neurologist or opthalmologist) Exclusion Criteria: 1.) Unable to consent (e.g. language, mental retardation).
Where it's running
-
The Danish Headache Center, Department of Neurology, Rigshospitalet-Glostrup
Copenhagen, Glostrup, Denmark Recruiting -
Odense University Hospital, Department of Neurology
Odense, Region Syddanmark, Denmark Recruiting
Study contacts
- Study coordinator: Johanne Severinsen, M.D.
- Email: johanne.juhl.severinsen@regionh.dk
- Phone: 004538633553
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Selective activation of the adrenomedullin receptor to provoke migraine in adults with migraine without aura
This study tests whether selectively activating the adrenomedullin receptor can trigger migraine attacks in adults who have migraine without aura, after blocking CGRP receptors.
-
Does adrenomedullin trigger migraine-like headaches in people with persistent post-traumatic headache?
This trial will test if a short intravenous infusion of the neuropeptide adrenomedullin can trigger migraine-like headaches in adults with long-standing post-traumatic headache after a single mild head injury.
-
Triggering migraine aura with CGRP
This trial will try giving calcitonin gene-related peptide (CGRP) to adults with migraine with aura to see if it triggers their aura.
-
Investigating the role of Substance P in triggering migraine attacks
This study is trying to see if a substance called Substance P can trigger migraine attacks in people who usually get migraines without aura.
-
Using Botox to treat posttraumatic headaches
This study is testing if Botox can help people with posttraumatic headaches feel better by reducing how often and how badly they hurt.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.